Clinical Trials Logo

Lateral Canthal Lines clinical trials

View clinical trials related to Lateral Canthal Lines.

Filter by:

NCT ID: NCT00968942 Completed - Facial Wrinkles Clinical Trials

Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Start date: August 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of 2 sequential doses of RT001 compared to placebo gel to treat moderate to severe lateral canthal lines in adults.

NCT ID: NCT00968825 Completed - Facial Wrinkles Clinical Trials

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Start date: July 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of a single administration of RT001 compared to placebo gel for the treatment of moderate to severe lateral canthal lines.

NCT ID: NCT00907387 Completed - Clinical trials for Lateral Canthal Lines

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Start date: April 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of RT001 to treat moderate to severe lateral canthal lines in adults and duration of effect.

NCT ID: NCT00888914 Completed - Facial Wrinkles Clinical Trials

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Start date: November 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of RT001 to treat moderate to severe lateral canthal lines in adults.

NCT ID: NCT00884234 Completed - Clinical trials for Lateral Canthal Lines

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Start date: February 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of 2 sequential doses of RT001 compared to vehicle control following applications at Baseline (Day 0) and Week 2.

NCT ID: NCT00247559 Completed - Clinical trials for Lateral Canthal Lines

Botulinum Type A Toxin in the Treatment of Lateral Canthal Lines (Crow's Feet)

Start date: May 2004
Phase: Phase 2
Study type: Interventional

Despite the wealth of information in the literature regarding the cosmetic applications of botulinum type A toxin (BoNT-A), and the widespread use of the BoNT-A for cosmetic applications, the number of randomised, controlled clinical trials is small. Much of the published information is based on open-label studies or anecdotal data. Of the robust trial data that is available, the vast majority relates to the treatment of glabellar lines, and there is little data available regarding the use of BoNT-A in lateral canthal lines. This study aims to determine the optimum dose for the use of BoNT-A in this area.